The latest price target for Sio Gene Therapies Inc (OTC:SIOX) was reported by HC Wainwright & Co. on April 28, 2022. The analyst firm set a price target for $0.00 expecting SIOX to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.

The latest analyst rating for Sio Gene Therapies Inc (OTC:SIOX) was provided by HC Wainwright & Co., and Sio Gene Therapies Inc downgraded their sell rating.

There is no last upgrade for Sio Gene Therapies Inc

The last downgrade for Sio Gene Therapies Inc happened on April 28, 2022 when HC Wainwright & Co. changed their price target from N/A to N/A for Sio Gene Therapies Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Sio Gene Therapies Inc, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Sio Gene Therapies Inc was filed on April 28, 2022 so you should expect the next rating to be made available sometime around April 28, 2023.

While ratings are subjective and will change, the latest Sio Gene Therapies Inc (SIOX) rating was a downgraded with a price target of $0.00 to $0.00. The current price Sio Gene Therapies Inc (SIOX) is trading at is $0.45, which is out of the analyst’s predicted range.